Mindfulness-Based Relapse Prevention for Substance Use Disorders: Effects on Cardiac Vagal Control and Craving Under Stress.
Mindfulness-Based Relapse Prevention for Substance Use Disorders: Effects on Cardiac Vagal Control and Craving Under Stress.
复制标题
DOI：
10.1007/s12671-017-0791-1
复制
发表时间：
2018-04
期刊：
影响因子：
3.6
通讯作者：
B Lustyk MK
中科院分区：
文献类型：
--
作者：
Carroll H;B Lustyk MK
基于正念的复吸预防 (MBRP) 是一种针对成瘾行为的疗法，它将认知行为复吸预防 (RP) 技能与正念训练相结合，以提高高风险情况下的意识和熟练的行动。压力是药物滥用复发的常见原因，使用生理测量来测量压力参与可能有助于我们确定临床改善的机制。具体来说，治疗后 HF-HRV 的致敬性变化可以作为治疗效果的标志。我们研究了 8 周的 RP、MBRP 或排毒后治疗（称为常规治疗）后，认知应激源（即算术挑战）的强直性和阶段性心率变异性 (HRV)（TAU；n = 34）。与 RP 和 TAU 相比，MBRP 与较高水平的强直性和阶段性 HF-HRV、较低水平的焦虑以及较低的心率反应性（仅与 TAU 相比）相关。这表明完成 MBRP 的人正在应对压力，但可能是以一种更具适应性、更灵活的方式。 MBRP 与较高的心脏迷走神经控制和较低的应激/焦虑反应相关。鉴于负面情绪是复发的重要组成部分，这些结果进一步证明正念可能对药物滥用障碍患者有帮助。
Mindfulness-based relapse prevention (MBRP) is a therapy for addictive behaviors that incorporates cognitive-behavioral relapse prevention (RP) skills with mindfulness training to increase awareness and skillful action in high-risk situations. Stress is a common reason reported for substance use relapse, and using physiological measures to measure stress engagement may help us identify mechanisms of clinical improvement. Specifically, salutatory changes in HF-HRV post-treatment may serve as a marker of treatment efficacy. We investigated tonic and phasic heart rate variability (HRV) to a cognitive stressor (i.e., arithmetic challenge) following 8 weeks of RP, MBRP, or post-detox treatment known as treatment as usual (TAU; n = 34). MBRP was related to higher levels of tonic and phasic HF-HRV, lower levels of anxiety, and lower heart rate reactivity (than TAU only) compared to RP and TAU. This suggests that those who completed MBRP are engaging with stress, but perhaps in a more adaptive, flexible manner. MBRP is associated with higher cardiac vagal control and lower stress/anxious reactivity. Given that negative emotions are an important component of relapse, these results lend further support to say that mindfulness may be helpful for those with substance use disorders.
登录
查看更多内容
影响因子：
3.3
作者：
Bylsma LM;Salomon K;Taylor-Clift A;Morris BH;Rottenberg J
通讯作者：
Rottenberg J
影响因子：
3.7
作者：
Chambers, AS;Allen, JJB
通讯作者：
Allen, JJB
影响因子：
3.4
作者：
Bowen, Sarah;Witkiewitz, Katie;Marlatt, G. Alan
通讯作者：
Marlatt, G. Alan
影响因子：
25.8
作者：
Bowen, Sarah;Witkiewitz, Katie;Clifasefi, Seema L.;Grow, Joel;Chawla, Neharika;Hsu, Sharon H.;Carroll, Haley A.;Harrop, Erin;Collins, Susan E.;Lustyk, M. Kathleen;Larimer, Mary E.
通讯作者：
Larimer, Mary E.
焦虑症与心率变异性降低有关：荟萃分析。
影响因子：
4.7
作者：
Chalmers JA;Quintana DS;Abbott MJ;Kemp AH
通讯作者：
Kemp AH